Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis

NARecruitingINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Distal Lateral Subungual OnychomycosisOnychomycosis
Interventions
DEVICE

Nail Genesis DLSO Product

Nail fungus is difficult to treat with topical drugs because of the thickness of the nails (Murdan, 2002). Nail Genesis DLSO Product does not contain a drug or antifungal agent and so is not designed to have a direct action on the microorganism, but instead will act by changing the conditions that allow growth of the fungus (i.e., keeping the nail plate and underlying nail bed dry and inhibiting secondary infection).

DEVICE

Nail Genesis DLSO Product (vehicle only)

The Nail Genesis DLSO product poly-urethane vehicle

Trial Locations (10)

14609

RECRUITING

Rochester Clinical Research, LLC, Rochester

24501

RECRUITING

The Education & Research Foundation, Inc., Lynchburg

33143

RECRUITING

Doctors Research Network, South Miami

55112

NOT_YET_RECRUITING

Minnesota Clinical Study Center, New Brighton

72703

RECRUITING

Clinical Trials Institute of Northwest Arkansas, Fayetteville

77055

RECRUITING

West Houston Clinical Research Service, Houston

78759

RECRUITING

DermResearch, Austin

91763

RECRUITING

Catalina Research Institute, LLC, Montclair

92404

RECRUITING

Metro Clinical Trials, San Bernardino

95821

RECRUITING

Northern California Research, Sacramento

All Listed Sponsors
lead

Nail Genesis LLC

INDUSTRY